15 Ways Graphene Could Change Everything...

Visual Capitalist |


While the properties and applications of graphene are extremely enticing, there has one big traditional challenge with graphene: the cost of getting it.

The Ever-Changing Graphene Price

As you can imagine, synthesizing a material that is one atom thick is a process that has some major limitations. Since a sheet of graphene 1 mm thick (1/32 of an inch) requires three million layers of atoms, graphene has been quite cost-prohibitive to produce in large amounts.

Back in 2013, Nature reported that one micrometer-sized flake of graphene costed more than $1,000, which made graphene one of the most expensive materials on Earth. However, there has been quite some progress in this field since then, as scientists search for the “Holy Grail” in scaling graphene production processes.



By the end of 2015, Deloitte estimated that the market price per gram was close to $100. And today, graphene can now be ordered straight from a supplier like Graphenea, where multiple products are offered online ranging from graphene oxide (water dispersion) to monolayer graphene on silicon wafers.

One producer, NanoXplore, even estimates that graphene is now down to a cost of $0.10 per gram for good quality graphene, though this excludes graphene created through a CVD process (recognized as the highest level of quality available for bulk graphene).

The following graphic from Nature (2014) shows some methods for graphene production – though it should be noted that this is a quickly-changing discipline.

Graphene Production

As the price of graphene trends down at an impressive rate, its applications will continue to grow. However, for graphene to be a true game-changer, it will have to be integrated into the supply chains of manufacturers, which will still take multiple years to accomplish.

Once graphene has “real world” applications, we’ll be able to see what can be made possible on a grander scale.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…